Compared with thymocyte Drp1-knockout mice, PD-1 inhibitors significantly enhanced the anti-tumor effect of wild-type mice, and this difference was related to the phosphorylation level of Drp1 in T cells (78). Here, DNM1L is linked to neoplasm.